Genome Editing/ Genome Engineering Market worth 5.54 Billion USD by 2021
The report "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN),
Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User
(Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021", that analyzes and
studies the major market drivers, restraints/challenges, and opportunities.
http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market231037000.html
This report studies the global genome editing market for the forecast period of 2016 to 2021. This market
is expected to reach USD 5.54 Billion by 2021 from USD 2.84 Billion in 2016, growing at a CAGR of
14.3%.
The global genome editing market is segmented on the basis of technology, application, end user and
region.
By technology, the genome editing market is categorized into CRISPR, TALEN, ZFN, antisense, and
other technologies (PiggyBac, Flp-In, and Jump-In). In 2016, the CRISPR segment is expected to
command the largest share of the global genome editing market. The CRISPR segment is also expected
to grow at the highest CAGR from 2016 to 2021. The large market share and high growth rate of this
technology segment can be attributed to the ease of use associated with the technology and reduction in
off-target effect of CRISPR.
On the basis of applications, the global genome editing market is segmented into cell line engineering,
animal genetic engineering, plant genetic engineering, and other applications (diagnostics and
therapeutics). The cell line engineering segment is estimated to account for the largest share of the global
genome editing market in 2016. This segment is also projected to have the highest growth rate in the
forecast period. A number of factors such as increasing funding from governments and private
organizations, growing industry focus on stem cell research, and increasing global awareness about stem
cell therapies through various organizations are driving the growth of the cell line engineering applications
segment
On the basis of end user, the global genome editing market is segmented biotechnology &
pharmaceutical companies, academic & government research institutes, and contract research
organizations. The biotechnology & pharmaceutical companies segment is estimated to account for the
largest share of the global genome market in 2016. This segment is also projected to have the highest
growth rate in the forecast period. Factors such as the rapidly increasing aging population and the
growing prevalence of infectious diseases and cancer have propelled the demand for genome editing
market for biotechnology & pharmaceutical companies.
On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the
Rest of the World. In 2016, North America is poised to account for the largest share of the genome editing
market market, followed by Europe and Asia-Pacific. North America is also projected to have the highest
growth rate in the forecast period. Factors such as the development of gene therapy in the U.S.;
increasing use of GM crops; prevalence of Alzheimer’s disease, dementia, infectious diseases, and